Hims & Hers Health shares rose Monday after the Food and Drug Administration said compounding pharmacies could continue to ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

CNBC's Karen Gilchrist weighs in on Zealand Pharma's "next generation" obesity drug candidate and its search for a global ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Unemployed people living with obesity could be given new weight loss jabs to help them get back into work, the health ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources ...

Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...